The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

(2010) Joanne L. Jones et al.   BRAIN

Interferon-β therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism

(2009) David Azoulay et al.   JOURNAL OF NEUROIMMUNOLOGY

Effect of IFN-ß therapy on the frequency and function of CD4+CD25+ regulatory T cells and Foxp3 gene expression in relapsing–remitting multiple sclerosis (RRMS): A preliminary study

(2009) Afshin Namdar et al.   JOURNAL OF NEUROIMMUNOLOGY

Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse

(2009) Elizabeth Regina Comini Frota et al.   NEUROSCIENCE LETTERS

Interferon Beta–Induced Restoration of Regulatory T-Cell Function in Multiple Sclerosis Is Prompted by an Increase in Newly Generated Naive Regulatory T Cells

(2008) Mirjam Korporal et al.   ARCHIVES OF NEUROLOGY

A longitudinal observation of Brain-Derived Neurotrophic Factor mRNA levels in patients with Relapsing–Remitting Multiple Sclerosis

(2008) Maria Liguori et al.   BRAIN RESEARCH

Interferon-β induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients

(2008) P.H. Lalive et al.   JOURNAL OF NEUROIMMUNOLOGY

Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection

(2008) David Azoulay et al.   JOURNAL OF NEUROIMMUNOLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET